Leaderboards/Nosocomial Infections in ICU

Nosocomial Infections in ICU

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Kirsty Sands
University of Oxford
2
Andrei Darie
The Alfred Hospital
3
Vadsala Baskaran
Nottingham Biomedical Research Centre
4
Gauthier Blonz
Centre Hospitalier Universitaire de Nantes
5
Melissa Dsouza
Lawrence General Hospital
6
Catherine Boschert
Bendigo Health
7
Weiwei Yang
Sichuan Cancer Hospital
8
Dashuai Wang
First Affiliated Hospital of Zhengzhou University
9
Aimei Yang
Lanzhou University of Technology
10
Ashka Patel
Dana-Farber Cancer Institute

Rising Stars Papers

1
Identification of a novel Providencia species showing multi-drug-resistant in three patients with hospital-acquired infection
International Journal of Antimicrobial Agents|2024
12 cit.
2
Preventing oxygen desaturation during bronchoscopy in COPD patients using high-flow oxygen <i>versus</i> standard management: the randomised controlled PROSA 2 trial
European Respiratory Journal|2025
11 cit.
3
Spread and evolution of blaKPC-plasmid between Serratia marcescens and Klebsiella pneumoniae
International Journal of Antimicrobial Agents|2024
8 cit.
4
Flies as carriers of antimicrobial resistant (AMR) bacteria in Nigerian hospitals: A workflow for surveillance of AMR bacteria carried by arthropod pests in hospital settings
Environment International|2025
8 cit.
5
Identification of blaKPC-90 in Klebsiella pneumoniae associated with ceftazidime-avibactam resistance and the translocation &amp; truncation of resistant genes mediated by IS26
International Journal of Antimicrobial Agents|2024
7 cit.
6
Comparative evaluation of DNA extraction protocols for neonatal gut microbiota profiling in a resource-limited setting
The Microbe|2025
6 cit.
7
Impact of donor age ≥65 years on graft survival in large lung transplant cohorts
The Journal of Heart and Lung Transplantation|2024
4 cit.
8
Beyond the samples: Nigerian research staff perspectives on a multicentre neonatal sepsis study’s impact
Nature Communications|2025
1 cit.
9
Acquisition of Escherichia coli carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger
Nature Communications|2025
1 cit.
10
Life-Supporting Treatment Limitations in Patients Who Die Within 48 Hours After ICU Admission: A French, Multicenter, Observational, Exploratory Study
Critical Care Explorations|2025
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jeroen Schouten
Radboud University Nijmegen
2
Andrea Gori
ASST Fatebenefratelli Sacco
3
David Pestaña
Universidad de Alcalá
4
Amélie Le Gouge
Centre Hospitalier Universitaire de Tours
5
Kordo Saeed
University Hospital Southampton NHS Foundation Trust
6
Yanjun Zhong
Central South University
7
Linghang Wang
Beijing Ditan Hospital
8
А. Затейщикова А.
Unknown
9
Candela Solé-Lleonart
Hospital Universitari de Vic
10
Hytham K. S. Hamid
Western Sydney University

Emerging Leaders Papers

1
Hydrocortisone in Severe Community-Acquired Pneumonia
New England Journal of Medicine|2023
434 cit.
2
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
Intensive Care Medicine|2023
246 cit.
3
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study
Critical Care|2022
58 cit.
4
A multicentre evaluation and expert recommendations of use of the newly developed BioFire Joint Infection polymerase chain reaction panel
European Journal of Clinical Microbiology & Infectious Diseases|2022
51 cit.
5
Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy
Journal of Critical Care|2023
24 cit.
6
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin
Respiratory Research|2022
16 cit.
7
The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections
Intensive Care Medicine|2024
12 cit.
8
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study
BJS Open|2024
11 cit.
9
Decision-making regarding antibiotic therapy duration: An observational study of multidisciplinary meetings in the intensive care unit
Journal of Critical Care|2023
10 cit.
10
Dynamic Changes of ORF1ab and N Gene Ct Values in COVID-19 Omicron Inpatients of Different Age Groups — Beijing Municipality, China, November–December 2022
China CDC Weekly|2023
8 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Mark H. Wilcox
University of Leeds
2
Marin H. Kollef
Washington University in St. Louis
3
Mitchell M. Levy
Brown University
4
Margaret A. Dudeck
Centers for Disease Control and Prevention
5
Antoní Torres
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
6
Scott K. Fridkin
Emory University
7
Jan Brożek
Cochrane
8
Victoria J. Fraser
University of Missouri–St. Louis
9
Dawn Sievert
Centers for Disease Control and Prevention
10
Jordi Rello
Centre Hospitalier Universitaire de Montpellier

Current Senior Leaders Papers

1
CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
American Journal of Infection Control|2008
6.6k cit.
2
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Intensive Care Medicine|2021
5k cit.
3
Multistate Point-Prevalence Survey of Health Care–Associated Infections
New England Journal of Medicine|2014
3.9k cit.
4
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Clinical Infectious Diseases|2016
3.9k cit.
5
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Intensive Care Medicine|2004
3.3k cit.
6
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Infection Control and Hospital Epidemiology|2010
2.9k cit.
7
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
Critical Care Medicine|2021
2.8k cit.
8
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
Clinical Infectious Diseases|2017
2.7k cit.
9
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
New England Journal of Medicine|2017
2.2k cit.
10
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
Journal of Allergy and Clinical Immunology|2017
2k cit.

Reagents for Nosocomial Infections in ICU

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

SRC-3 (11B1) Mouse Monoclonal Antibody

#2115$158,348
View Evidence →
Cell Signaling TechnologyEvidence 64

LIMP-2/SCARB2 (E2Z5F) Rabbit Monoclonal Antibody

#27960$160,351
View Evidence →
Cell Signaling TechnologyEvidence 66

ASCT2 (V501) Antibody

#5345$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

MYST2 (D4N3F) Rabbit Monoclonal Antibody

#58418$161,351
View Evidence →
Cell Signaling TechnologyEvidence 61

AsCpf1/Cas12a (Strain BV3L6) (E1U7C) Rabbit Monoclonal Antibody

#19984$175,354
View Evidence →
Cell Signaling TechnologyEvidence 64

Phospho-Syk (Tyr525/526) (C87C1) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#12081$191,493
View Evidence →